Lack of adverse effect of statin therapy on common muscle-related adverse events

Abstract

Get full access to this article

View all access options for this article.

References

Cholesterol Treatment Trialists’ (CTT). Collaboration. Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Am J Cardiol 1995; 75: 1130–1134.

Cholesterol Treatment Trialists’ (CTT) Collaboration (writing committee: Mihaylova B, Emberson J, Blackwell L, et al.). The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012; 380: 581–590.

Finegold

Manisty

Goldacre

. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. Eur J Prev Cardiol. Epub ahead of print 12 March 2014. DOI: 10.1177/204748731452553.

Armitage J. The safety of statins in clinical practice. Lancet. Epub ahead of print 7 June 2007. DOI:10.1016/S0140-6736(07)60716-8.